{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:20Z","timestamp":1793057120525,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.euf.2022.01.014","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T15:51:20Z","timestamp":1644076280000},"page":"1476-1482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference"],"prefix":"10.1016","volume":"8","author":[{"given":"Tommaso","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Tamanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Collini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brugnolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Migno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Tateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Pilatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Bonkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M.E.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls E.","family":"Bjerklund Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2022.01.014_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fmicb.2013.00029","article-title":"Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness","volume":"4","author":"Nordstrom","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.euf.2022.01.014_b0010","doi-asserted-by":"crossref","first-page":"105966","DOI":"10.1016\/j.ijantimicag.2020.105966","article-title":"Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study","volume":"56","author":"Cai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.euf.2022.01.014_b0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mda.2003.7","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"49","author":"Foxman","year":"2003","journal-title":"Dis Mon"},{"key":"10.1016\/j.euf.2022.01.014_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40261-013-0069-x","article-title":"An economic perspective on urinary tract infection: the \u201ccosts of resignation\u201d","volume":"33","author":"Ciani","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.euf.2022.01.014_b0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","article-title":"A prospective study of risk factors for symptomatic urinary tract infection in young women","volume":"335","author":"Hooton","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2022.01.014_b0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/iju.12453","article-title":"Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection","volume":"21","author":"Cai","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2022.01.014_b0035","article-title":"Independent validation of a predictive nomogram for risk of reinfection in women with recurrent non-complicated urinary tract infections. Ther","volume":"12","author":"Favoreto","year":"2020","journal-title":"Adv Urol"},{"key":"10.1016\/j.euf.2022.01.014_b0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/fmb-2019-0145","article-title":"Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study","volume":"14","author":"Cai","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.euf.2022.01.014_b0045","unstructured":"EAU. European Association of Urology guidelines on urological infections, update 2019. http:\/\/uroweb.org\/guideline\/urological-infections\/."},{"key":"10.1016\/j.euf.2022.01.014_b0050","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/civ696","article-title":"Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections","volume":"61","author":"Cai","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.euf.2022.01.014_b0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial","volume":"293","author":"Hooton","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2022.01.014_b0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.eururo.2006.10.059","article-title":"Interleukin 8 and anti-Chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection","volume":"51","author":"Mazzoli","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2022.01.014_b0065","first-page":"478","article-title":"Health status: types of validity and the index of wellbeing","volume":"11","author":"Kaplan","year":"1976","journal-title":"Health Serv Res"},{"key":"10.1016\/j.euf.2022.01.014_b0070","series-title":"Manual for the State-Trait Anxiety Inventory (Form Y)","author":"Spielberger","year":"1989"},{"key":"10.1016\/j.euf.2022.01.014_b0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3109\/02699052.2012.667589","article-title":"National Consortium Functioning and Disability in Vegetative and in Minimal Conscious State Patients. Burden and needs of 487 caregivers of patients in vegetative state and in minimally conscious state: results from a national study","volume":"26","author":"Leonardi","year":"2012","journal-title":"Brain Inj"},{"key":"10.1016\/j.euf.2022.01.014_b0080","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.3399\/bjgp20X712781","article-title":"Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review","volume":"70","author":"Hoffmann","year":"2020","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.euf.2022.01.014_b0085","article-title":"Risk factors and predisposing conditions for urinary tract infection. Ther","volume":"11","author":"Storme","year":"2019","journal-title":"Adv Urol"},{"key":"10.1016\/j.euf.2022.01.014_b0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/875512259200800606","article-title":"Patient treatment adherence. Facility design and counseling skills","volume":"8","author":"Allan","year":"1992","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.euf.2022.01.014_b0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00005650-197903000-00004","article-title":"Active patient orientation and outcomes in hypertensive treatment","volume":"17","author":"Schulman","year":"1979","journal-title":"Med Care"},{"key":"10.1016\/j.euf.2022.01.014_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4081\/aiua.2018.2.97","article-title":"L-methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: focus on antibiotic-sparing approach","volume":"90","author":"Cai","year":"2018","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.euf.2022.01.014_b0105","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41467-019-13467-w","article-title":"Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection","volume":"10","author":"Magruder","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.euf.2022.01.014_b0110","first-page":"CD008772","article-title":"Probiotics for preventing urinary tract infections in adults and children","volume":"2015","author":"Schwenger","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2022.01.014_b0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/cid\/cis534","article-title":"The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?","volume":"55","author":"Cai","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.euf.2022.01.014_b0120","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1080\/14656566.2020.1795128","article-title":"Pharmacotherapeutic advances for recurrent urinary tract infections in women","volume":"21","author":"Moussa","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.euf.2022.01.014_b0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euf.2019.11.002","article-title":"Role of vaccines for recurrent urinary tract infections: a systematic review","volume":"6","author":"Prattley","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2022.01.014_b0130","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/cid\/ciz1207","article-title":"Weekly sequential antibioprophylaxis for recurrent urinary tract infections among patients with neurogenic bladder: a randomized controlled trial","volume":"71","author":"Dinh","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456922000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456922000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:55:24Z","timestamp":1762498524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456922000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2405456922000372"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2022.01.014","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2022.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}